Drug Information

Drug General Information
Drug ID
D0I1FQ
Former ID
DAP001510
Drug Name
Raltegravir
Synonyms
RGV; MK 0518; Isentress(TM); K-0518; MK-0518; Raltegravir (INN); N-(2-(4-(4-fluorobenzylcarbamoyl); N-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-4-pyrimidinecarboxamide; RAL
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Approved [529282]
Structure
Download
2D MOL

3D MOL
Formula
C20H21FN6O5
CAS Number
CAS 871038-72-1
PubChem Compound ID
11598201
SuperDrug ATC ID
J05AX08
Drug Resistance Mutation (DRM)
DRM DRM Info
Target and Pathway
Target(s) HIV integrase Target Info Modulator [529282]
References
Ref 5292822007 FDA drug approvals: a year of flux. Nat Rev Drug Discov. 2008 Feb;7(2):107-9.
Ref 5292822007 FDA drug approvals: a year of flux. Nat Rev Drug Discov. 2008 Feb;7(2):107-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.